Research has noted that stimulant-based PCEs have addictive potential in healthy users due to their effects on neurotransmitter systems, particularly dopamine and glutamate. The enhancement of dopamine transmission and the modulation of glutamatergic signaling are both associated with reward and reinforcement pathways in the brain. This neuro-chemical activity contributes to their habit-forming qualities, raising concerns about dependency in non-clinical populations.